ABBATTISTA, MARIA
ABBATTISTA, MARIA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Cerebral Small Vessel Disease in Immune‐Mediated Thrombotic Thrombocytopenic Purpura Patients During the Acute Phase and Disease Remission
2026 A. Truma, F.M.L. Russo, G. Conte, I. Mancini, A. Artoni, J.A. Giannotta, B. Ferrari, P. Agosti, M. Abbattista, M. Gagliardi, E. Piccin, M. Stroppi, F.M. Triulzi, F. Peyvandi
The risk of cerebral vein thrombosis associated with different types of combined hormonal contraceptives: a case-control study
2025 M. Abbattista, A. Truma, I. Martinelli, F. Gianniello, S.M. Passamonti, M. Capecchi, A. Artoni, F. Peyvandi, P. Bucciarelli
Activated Clotting Time Measured by Hemochron Signature Elite in Adult Cardiac Surgery: Implications for Clinical Practice
2025 F.M. Russo, A. Artoni, M. Cotza, G. Veronese, S. Cenci, M. Villano, N. Di Tomasso, G. Pedrazzini, M. Abbattista, C. Novembrino, M. Anguissola, R. Cardani, F. Peyvandi, M. Ranucci, G. Grasselli
Gut Microbiome Diversity and Composition Correlates With Time in the Therapeutic Range in Patients on Warfarin Treatment: A Pilot Study
2024 P. Agosti, A. Kouraki, T. Dionisi, G. Addolorato, L. D'Innocenzo, S. Sorrentino, F. De Maio, E. De Candia, A. Blanco-Miguez, D. Bazzani, A. Bonadiman, G. Tonidandel, M. Bolzan, F. Gianniello, S.M. Passamonti, M. Abbattista, A.M. Valdes, P. Bucciarelli, F. Peyvandi, C. Menni
Prediction of venous thromboembolism in average-risk, young candidates for oral contraceptive use: to genotype, or not to genotype, that is the question
2024 P. Vercellini, A. Artoni, M. Abbattista, I. Martinelli, C. Pillinini, F. Forzano
Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients
2023 M. Capecchi, P. De Leo, M. Abbattista, I. Mancini, P. Agosti, M. Biganzoli, C. Suffritti, B. Ferrari, A. Lecchi, S. La Marca, L. Padovan, E. Scalambrino, M. Clerici, A. Tripodi, A. Artoni, R. Gualtierotti, F. Peyvandi
Hemorrhagic and thrombotic adverse events associated with emicizumab and extended half-life factor VIII replacement drugs: EudraVigilance data of 2021
2023 M. Abbattista, A. Ciavarella, D. Noone, F. Peyvandi
Fitusiran in haemophilia: a breakthrough drug with many unknowns
2023 F. Peyvandi, I. Garagiola, M. Abbattista
Plasma levels of extracellular vesicles and the risk of post-operative pulmonary embolism in patients with primary brain tumors: a prospective study
2021 S.M. Passamonti, A. Artoni, G. Carrabba, G. Merati, M. Abbattista, M. Capecchi, M. Castellani, C. Marenghi, E. Trombetta, L. Giammattei, M. Caroli, P. Bucciarelli, E. Scalambrino, F. Peyvandi, I. Martinelli
Increasing dosages of low-molecular-weight heparin in hospitalized patients with Covid-19
2021 I. Martinelli, A. Ciavarella, M. Abbattista, S. Aliberti, V. De Zan, C. Folli, M. Panigada, A. Gori, A. Artoni, A.M. Ierardi, G. Carrafiello, V. Monzani, G. Grasselli, F. Blasi, F. Peyvandi
Risk factors for mortality in hospitalized patients with COVID-19: a study in Milan, Italy
2020 M. Abbattista, A. Ciavarella, M. Capecchi, F. Tantardini, A. Gramegna, R. Lombardi, N. Scaramellini, F. Peyvandi, I. Martinelli
Treatment of unusual thrombotic manifestations
2020 M. Abbattista, M. Capecchi, I. Martinelli
Pregnancy after cerebral venous thrombosis
2019 M. Abbattista, M. Capecchi, I. Martinelli
Cerebral venous sinus thrombosis
2018 M. Capecchi, M. Abbattista, I. Martinelli
Hemostatic abnormalities in patients with Ehlers–Danlos syndrome
2018 A. Artoni, A. Bassotti, M. Abbattista, B. Marinelli, A. Lecchi, F. Gianniello, M. Clerici, P. Bucciarelli, S. La Marca, F. Payvandi, I. Martinelli
Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban
2018 I. Martinelli, M. Abbattista, P. Bucciarelli, A. Tripodi, A. Artoni, F. Gianniello, C. Novembrino, F. Peyvandi